| 47064-1 |
Epstein Barr virus capsid Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
IF |
|
ACTIVE |
Epstein Barr virus capsid IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47064-1 |
|
IF |
|
|
Both |
|
|
|
0 |
EBV VCA IgG Titr Fld IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CAP; Dilution factor; Dilution Factor (Titer); EBV; EBV capsid Ab; EBV VCA; Epstn; FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; HHV-4; human herpesvirus 4; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Point in time; Random; SmQn; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; VCA; Viral capsid |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47065-8 |
Rickettsia typhi Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Rickettsia typhi IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47065-8 |
|
IF |
|
|
Both |
|
|
|
0 |
R typhi IgG Titr CSF IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); Endemic typhus; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Murine typhus; Neuro; Neurology; Point in time; R typhi; Random; Ricket; Rickettsial; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Typh; Typhus |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47066-6 |
Epstein Barr virus capsid Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
IF |
|
ACTIVE |
Epstein Barr virus capsid IgM Ab [Titer] in Body fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47066-6 |
|
IF |
|
|
Both |
|
|
|
0 |
EBV VCA IgM Titr Fld IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CAP; Dilution factor; Dilution Factor (Titer); EBV; EBV capsid Ab; EBV VCA; Epstn; FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; HHV-4; human herpesvirus 4; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Point in time; Random; SmQn; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; VCA; Viral capsid |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47067-4 |
Rickettsia typhi Ab.IgM |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Rickettsia typhi IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47067-4 |
|
IF |
|
|
Both |
|
|
|
0 |
R typhi IgM Titr CSF IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); Endemic typhus; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Murine typhus; Neuro; Neurology; Point in time; R typhi; Random; Ricket; Rickettsial; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Typh; Typhus |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47068-2 |
Epstein Barr virus early Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
IF |
|
ACTIVE |
Epstein Barr virus early IgG Ab [Titer] in Body fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47068-2 |
|
IF |
|
|
Both |
|
|
|
0 |
EBV EA IgG Titr Fld IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); EA; EBV; EBV EA; Epstn; FA; Fl; Fld; FLU; Fluid; Fluorescent antibody; Fluoresent; HHV-4; human herpesvirus 4; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Point in time; Random; SmQn; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47069-0 |
Rickettsia rickettsii Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Rickettsia rickettsii IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47069-0 |
|
IF |
|
|
Both |
|
|
|
0 |
R rickettsi IgG Titr CSF IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; R rickettsi; R rickettsii; Random; Ricket; Rickettsial; RMSF; Rocky mountain spotted fever; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Spotted fever; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 4707-6 |
HLA-A68(28) |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-A68(28) [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4707-6 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-A68(28) Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47070-8 |
Rickettsia rickettsii Ab.IgM |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Rickettsia rickettsii IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47070-8 |
|
IF |
|
|
Both |
|
|
|
0 |
R rickettsi IgM Titr CSF IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; R rickettsi; R rickettsii; Random; Ricket; Rickettsial; RMSF; Rocky mountain spotted fever; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Spotted fever; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47071-6 |
Babesia microti Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Babesia microti IgG Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47071-6 |
|
|
|
|
Both |
|
|
|
0 |
B microti IgG Titr CSF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B microti; Babesiosis; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Piroplasmosis; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47072-4 |
Epstein Barr virus early Ab.IgA |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Epstein Barr virus early IgA Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47072-4 |
|
IF |
|
|
Both |
|
|
|
0 |
EBV EA IgA Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EA; EBV; EBV EA; Epstn; FA; Fluorescent antibody; Fluoresent; HHV-4; human herpesvirus 4; ID; IFA; Immune fluorescence; Immune globulin A; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47073-2 |
Babesia microti Ab.IgM |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Babesia microti IgM Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47073-2 |
|
|
|
|
Both |
|
|
|
0 |
B microti IgM Titr CSF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B microti; Babesiosis; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Piroplasmosis; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47074-0 |
PCNA extractable nuclear Ab |
PrThr |
Ser |
Pt |
Ord |
IF |
|
ACTIVE |
PCNA extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
47074-0 |
|
IF |
|
|
Both |
|
|
|
0 |
ENA PCNA Ab Ser Ql IF |
|
|
|
N |
|
ABS; Aby; ACIF; ANA; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; ENA PCNA; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF |
2.73 |
2.19 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47075-7 |
Coxiella burnetii phase 1 Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Coxiella burnetii phase 1 IgM Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47075-7 |
|
IF |
|
|
Both |
|
|
|
0 |
C burnet Ph1 IgM Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnet Ph1; C burnetii; Coxiella burnetii phase I; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; i; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Q fev; Q fever; Qfever; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47076-5 |
Legionella pneumophila 7 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Legionella pneumophila 7 IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47076-5 |
|
IF |
|
|
Both |
|
|
|
0 |
L pneumo7 IgG Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Chicago 8; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; L pneumo; L pneumo7; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 7; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47077-3 |
Legionella pneumophila 7 Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Legionella pneumophila 7 IgM Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47077-3 |
|
IF |
|
|
Both |
|
|
|
0 |
L pneumo7 IgM Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Chicago 8; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; L pneumo; L pneumo7; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 7; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47078-1 |
Legionella pneumophila 8 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Legionella pneumophila 8 IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47078-1 |
|
IF |
|
|
Both |
|
|
|
0 |
L pneumo8 IgG Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Concord 3; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; L pneumo; L pneumo8; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 8; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47079-9 |
Legionella pneumophila 8 Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Legionella pneumophila 8 IgM Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47079-9 |
|
IF |
|
|
Both |
|
|
|
0 |
L pneumo8 IgM Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Concord 3; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; L pneumo; L pneumo8; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 8; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 4708-4 |
HLA-A68(28) |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-A68(28) [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4708-4 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-A68(28) Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47080-7 |
Legionella pneumophila 9 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Legionella pneumophila 9 IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47080-7 |
|
IF |
|
|
Both |
|
|
|
0 |
L pneumo9 IgG Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; IN 23; Infectious Disease; InfectiousDisease; L pneumo; L pneumo9; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 9; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47081-5 |
Legionella pneumophila 9 Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Legionella pneumophila 9 IgM Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47081-5 |
|
IF |
|
|
Both |
|
|
|
0 |
L pneumo9 IgM Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; IN 23; Infectious Disease; InfectiousDisease; L pneumo; L pneumo9; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 9; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47082-3 |
Legionella pneumophila 10 Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Legionella pneumophila 10 IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
47082-3 |
|
IF |
|
|
Both |
|
|
|
0 |
L pneumo 10 IgG Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; L pneumo; L pneumo 10; L pneumo 10 Ab; L pneumonphila; Legion; Legionela; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.19 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 47083-1 |
IgG |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
IgG [Mass/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
47083-1 |
|
|
|
|
Both |
|
|
|
0 |
IgG 24h Ur-mCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Immune globulin G; Immunoglobulin G; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.73 |
2.19 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 47084-9 |
Platelet glycoprotein Ia-IIa Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Platelet glycoprotein Ia/IIa Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
47084-9 |
|
IA |
|
|
Both |
|
|
|
0 |
Plat Gp Ia/IIa Ab Ser Ql IA |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; IAA; MEIA; Ordinal; Pl; Plat Gp; Plat Gp Ia/IIa; Platelets; Platelt; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS; Thrombocyte; Thrombocytes |
2.73 |
2.19 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47085-6 |
Plasmodium sp DNA |
PrThr |
Bld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Plasmodium sp DNA [Presence] in Blood by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
47085-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Plasmodium DNA Bld Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Malaria; Malarial; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Plasmodium DNA; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.73 |
2.19 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 47086-4 |
11-Hydroxyandrostenedione |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
11-Hydroxyandrostenedione [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
47086-4 |
|
|
|
|
Both |
|
|
|
0 |
11OH-Ad SerPl-sCnc |
|
|
|
N |
|
11-beta-hydroxyandrostenedione; 11-Hydroxy androstenedione; 11OH-Ad; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
